Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease (Front. Neurol., (2022), 12, 656342, 10.3389/fneur.2021.656342)

In the published article, there was an error. The stated number of protocols needed to be corrected. These errors were identified after an audit conducted by the CONIS (Consejo Nacional de Investigacion en Salud) of Costa Rica. A correction has been made to the Ethics Statement. This statement previously stated: The studies involving human participants were reviewed and approved by Ethics Committee of Hospital San Juan de Dios, Caja Costarricense de Seguro Social (CLOBI-HSJD #014- 2015) and the University of Costa Rica (837-B5-304). The patients/participants provided their written informed consent to participate in this study. The corrected statement appears below: The studies involving human participants were reviewed and approved by the Ethics Committee of the University of Costa Rica (VI-3668-2014 and final report 837-B5-302). The patients/participants provided their written informed consent to participate in this study. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Duke Scholars

Author Gabriel Torrealba-Acosta Neurology, Neurocritical Care